Abbasi Zahra, Ghasemi Seyed Mahdi, Ahmadi Yasaman, Shokri Dariush
Department of Microbiology, Faculty of Biological Sciences and Technology, Shahid Ashrafi Esfahani University, Isfahan, Iran.
Department of Microbiology, Kish International Branch of Islamic Azad University, Kish, Iran.
Can J Infect Dis Med Microbiol. 2024 Feb 26;2024:8570521. doi: 10.1155/2024/8570521. eCollection 2024.
This study aimed to identify, assess, and isolate strong lactobacilli demonstrating broad antibacterial and anti-biofilm activity against drug-resistant strains of . Additionally, the mechanism of inhibition of these organisms was to be determined.
Over a 6-month period (from December 2021 to June 2022), 53 clinical strains were collected from clinical samples. Twenty probiotic strains were isolated from local dairy products. Antibacterial activity of strains' cell-free supernatant (CFS) was identified using the agar well diffusion method and the microbroth dilution test. Anti-biofilm effect was performed by the microtiter plate assay. The MTT assay was also used to look into the probiotics' cytotoxic effects on the L929 fibroblast cell line.
During the 6-month period, 53 clinical strains were obtained and identified. Out of 20 strains, the CFS of a strain (named L9) showed an inhibitory effect against all strains. Using the broth microdilution method, it was shown that the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) of CFS extracts of L9 strains against strains were both ¼ mg/mL. The result of the anti-biofilm showed that the selected probiotic could inhibit biofilm formation. The most common organic acid produced by all strains, according to the HPLC method, was lactic acid, which was followed by acetic acid. The L929 fibroblast cell line was used in the cytotoxicity assay, which revealed that 100% of the cells in the L929 fibroblast cell line survived treatment with successive doses of CFSs for a full day.
The probiotic strain isolated from local yogurt in this study showed potential anti-biofilm and antimicrobial properties against all drug-resistant isolates. Given the increasing interest in probiotic microorganisms based on their high health benefits, further studies are recommended on the mechanisms of action between probiotics and strains to find new solutions for biological control and treatment of these infections without the use of antibiotics.
本研究旨在鉴定、评估和分离对耐药菌株具有广泛抗菌和抗生物膜活性的强乳酸菌。此外,还将确定这些微生物的抑制机制。
在6个月期间(从2021年12月至2022年6月),从临床样本中收集了53株临床菌株。从当地乳制品中分离出20株益生菌菌株。使用琼脂孔扩散法和微量肉汤稀释试验鉴定菌株无细胞上清液(CFS)的抗菌活性。通过微量滴定板试验进行抗生物膜作用。MTT试验也用于研究益生菌对L929成纤维细胞系的细胞毒性作用。
在6个月期间,获得并鉴定了53株临床菌株。在20株菌株中,一株菌株(命名为L9)的CFS对所有菌株均显示出抑制作用。使用肉汤微量稀释法表明,L9菌株CFS提取物对菌株的最低抑菌浓度(MICs)和最低杀菌浓度(MBCs)均为1/4mg/mL。抗生物膜结果表明,所选益生菌可抑制生物膜形成。根据HPLC方法,所有菌株产生的最常见有机酸是乳酸,其次是乙酸。在细胞毒性试验中使用了L929成纤维细胞系,结果显示,连续剂量的CFS处理一整天后,L929成纤维细胞系中100%的细胞存活。
本研究从当地酸奶中分离出的益生菌菌株对所有耐药菌株均显示出潜在的抗生物膜和抗菌特性。鉴于基于益生菌微生物的高健康益处,人们对其兴趣日益增加,建议进一步研究益生菌与菌株之间的作用机制,以找到无需使用抗生素即可对这些感染进行生物控制和治疗的新解决方案。